PubRank

Sanjay Sinha

Author PubWeight™ 29.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 2003 3.99
2 Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 2004 2.94
3 Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol 2012 1.94
4 A transforming growth factor-beta control element required for SM alpha-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression. J Biol Chem 2003 1.90
5 5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. J Clin Invest 2005 1.62
6 Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead. Indian J Med Res 2013 1.21
7 Stem cells and their derivatives can bypass the requirement of myocardin for smooth muscle gene expression. Dev Biol 2005 1.08
8 Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation. J Mol Cell Cardiol 2011 0.96
9 Embryological-origin-dependent differences in homeobox expression in adult aorta: role in regional phenotypic variability and regulation of NF-κB activity. Arterioscler Thromb Vasc Biol 2013 0.92
10 Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β. Arterioscler Thromb Vasc Biol 2013 0.90
11 Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty. Circulation 2003 0.88
12 Clinical outcome of cadaveric renal allografts contaminated before transplantation. Transpl Int 2005 0.87
13 Breast carcinoma in diabetic mastopathy. Breast 2005 0.84
14 Myocardin overexpression is sufficient for promoting the development of a mature smooth muscle cell-like phenotype from human embryonic stem cells. PLoS One 2012 0.83
15 Successful splenic venous drainage for kidney transplant in case of inferior vena cava thrombosis. Transplantation 2011 0.83
16 Migration of intra-vascular metallic stent into pulmonary artery. Nephrol Dial Transplant 2002 0.82
17 ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development. Am J Physiol Heart Circ Physiol 2004 0.81
18 Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol. Transplant Res 2013 0.78
19 Impact of pulsatile perfusion on postoperative outcome of kidneys from controlled donors after cardiac death. Transpl Int 2008 0.78
20 Policies for replacing long-term indwelling urinary catheters in adults. Cochrane Database Syst Rev 2016 0.77
21 Vascular disease in a dish: all the right ingredients? Circulation 2012 0.76
22 Intravesical treatment of painful bladder syndrome: the potential pitfalls of meta-analyses. Int Urogynecol J 2012 0.75
23 Revascularization of the gastro-epiploic artery in pancreas transplant. Transpl Int 2008 0.75
24 Renal function in type 1 diabetics one year after successful pancreas transplantation. Clin Transplant 2011 0.75
25 Reply to Letter: "Utilization of Small Pediatric Donors Including Infants for Pancreas and Kidney Transplantation: Exemplification of the Surgical Technique and Surveillance". Ann Surg 2015 0.75
26 Complex arterial reconstruction for pancreas transplantation in recipients with advanced arteriosclerosis. Transplantation 2008 0.75
27 Temporal and embryonic lineage-dependent regulation of human vascular SMC development by NOTCH3. Stem Cells Dev 2015 0.75
28 Management of a ruptured mycotic pseudo-aneurysm following pancreas-kidney transplantation. Ann Transplant 2012 0.75
29 Recurrent graft pancreatitis in a pancreatico-renal allograft recipient does not affect endocrine function. Transpl Int 2002 0.75
30 Postradiation angiosarcoma of bladder with extensive osseous metaplasia. Indian J Pathol Microbiol 2016 0.75
31 Risk analysis for deterioration of renal function after pancreas alone transplant. Clin Transplant 2011 0.75
32 Risk factors for delayed graft function defined as need for dialysis or failure of creatinine to fall by 10% in the first 24 hours after transplant. Exp Clin Transplant 2008 0.75
33 DCD pancreas transplantation meta-analysis: ethical and technical considerations. Transplantation 2016 0.75
34 Repulsive body odour due to cyclosporin A. Transpl Int 2002 0.75
35 A spectrum of oncocytic lesions in the parotid gland of a patient with sarcoidosis. Pathology 2012 0.75
36 Use of gonadal vein interposition graft for implantation of polar artery in live donor renal transplantation. Transplantation 2010 0.75
37 Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells. Development 2016 0.75
38 Unique vascular intervention to rescue a pancreas allograft after technical SMA occlusion. Transplantation 2011 0.75
39 Renal function and cardiovascular outcomes after living donor nephrectomy in the UK: quality and safety revisited. BJU Int 2013 0.75
40 App to reality: snapshot validation of the US Pancreas Donor Risk Index in a UK center. J Surg Res 2013 0.75